Vicki Moore, PhD

Contributing Writer https://www.hematologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Bleeding Disorders

Coagulation Disorders and Bleeding Risks With Cefoperazone-Sulbactam

Vicki Moore, PhD

February 10, 2020

Of patients who received cefoperazone-sulbactam, 9.2% reported a coagulation disorder and 15.7% reported a decrease in platelet count.

Leukemia

Survival Trends With Chronic Lymphocytic Leukemia Over 28 Years in the Netherlands

Vicki Moore, PhD

February 6, 2020

Relative survival rates were found to improve for all patient age groups over time, although excess mortality persisted to some degree.

Lymphoma

Pixantrone or Gemcitabine and Rituximab for Relapsed, Aggressive B-Cell Non-Hodgkin Lymphoma

Vicki Moore, PhD

February 4, 2020

Patients receiving pixantrone plus rituximab and patients receiving gemcitabine plus rituximab experienced similar progression-free survival.

Thalassemias

Novel Conditioning Regimen for Haploidentical HSCT in Severe Thalassemia

Vicki Moore, PhD

February 4, 2020

Both event-free and overall survival at 3 years were 96% for patients with transfusion-dependent thalassemia who underwent transplant.

Thrombotic Disorders

Thrombosis Risk With Immune Thrombocytopenia

Vicki Moore, PhD

February 3, 2020

In multivariate analysis, history of atrial fibrillation and smoking were associated with risk for thrombosis in patients newly diagnosed with immune thrombocytopenia.